Warfarin (Jantoven): Uses, Warnings, and Key Facts

What is warfarin?

Warfarin is a medicine used as an anticoagulant, which means it helps reduce the blood’s ability to clot. The content provided lists warfarin potassium and warfarin sodium as product ingredients.

In the United States, brand names mentioned for warfarin include Coumadin and Jantoven.

What is warfarin used for?

According to the source content, warfarin is used for:

• Prophylaxis and/or treatment of venous thrombosis.
• Pulmonary embolism.
• Prophylaxis and/or treatment of thromboembolic complications associated with atrial fibrillation and/or replacement of cardiac valves.
• After acute myocardial infarction, to reduce the risk of death due to recurrent myocardial infarction or thromboembolic episodes such as stroke or systemic embolization.

How warfarin works

Warfarin works by inhibiting vitamin K–dependent gamma-carboxylation in the liver. This reduces the formation of active clotting factors II, VII, IX, and X.

Because of this mechanism, warfarin’s effect can vary and is usually monitored with INR testing.

Typical dosing information

The source content gives general dosing ranges only:

• Initial dose: 2–5 mg/day
• Maintenance dose: 2–10 mg/day

Doses are individualized according to INR, and the target INR mentioned in the source is between 2.0 and 3.5 depending on the condition being treated.

For exact dosing instructions, readers should check the official prescribing information and follow the clinician’s plan.

Contraindications listed in the source

The original content lists the following situations where warfarin should not be used:

• Hypersensitivity.
• Pregnancy.
• Lack of cooperation on the part of the patient.
• Hemorrhagic diathesis and/or blood dyscrasia.
• Organic lesions susceptible to bleeding.
• Recent or planned surgery in the CNS, ophthalmological operations, or operations exposing large tissue surfaces.
• Gastroduodenal ulcer or bleeding in the gastrointestinal, urogenital, or respiratory tracts; cerebrovascular hemorrhage; pericarditis; pericardial effusion; slow endocarditis.
• Severe high blood pressure; severe liver and kidney parenchymal disease.
• Increased fibrinolytic activity, such as after lung or prostate operations.
• High doses of NSAIDs, miconazole (general route and oral gel), phenylbutazone (general route), high doses of ASA, and other salicylates.

Warnings and precautions

The source highlights several important precautions with warfarin:

• Risk of hemorrhage.
• Risk of necrosis; if necrosis occurs, heparin substitution is mentioned in the source.
• Risk of release of emboli or atheromatous plaques.
• Extra caution in moderate to severe renal insufficiency, hepatic insufficiency, and high blood pressure.
• Infectious diseases or changes in intestinal flora may affect response.
• Catheters and deficiencies in protein C or protein S response may increase the risk of tissue necrosis.
• INR monitoring is important.
• The source states there are no data to support use in children.
• If calciphylaxis appears, treatment should be suspended according to the source.

Liver and kidney considerations

Liver failure

Warfarin is contraindicated in severe liver parenchymal disorders. The source advises caution in moderate to severe liver failure.

Renal insufficiency

Warfarin is contraindicated in severe renal parenchymal disorders. The source advises caution in moderate to severe renal insufficiency.

Interactions

Warfarin has many interactions. The source groups them by effect on anticoagulation.

Because the interaction list is extensive, readers should verify all medicines, supplements, and major diet changes with a pharmacist or prescriber.

Pregnancy and breastfeeding

Pregnancy

The source says warfarin is not recommended in pregnancy and crosses the placenta. It also lists reported fetal risks, including severe nasal hypoplasia, chondrodysplasia punctata, optic atrophy, microcephaly, and growth retardation when exposure occurs during the first trimester.

Breastfeeding

According to the source, very little warfarin is detected in breast milk, and unwanted effects in the infant are not expected. It also states that infants fed milk from mothers treated with warfarin do not show changes in prothrombin times.

Adverse reactions and side effects

The source lists bleeding into any organ as the main adverse reaction.

Any unusual bleeding, black stools, blood in urine, severe headache, or sudden weakness should be treated as urgent and discussed with a healthcare professional immediately.

Overdose information

The source provides INR-based management examples for overdose situations, including vitamin K1 and plasma, blood, or factor IX complex in severe bleeding. Because overdose management depends on the clinical situation, this should only be handled by emergency or specialist care.

Key points to verify with a doctor or pharmacist

• Your target INR range.
• Which foods, supplements, and medicines may affect warfarin.
• How often INR monitoring is needed.
• Whether warfarin is appropriate in pregnancy, breastfeeding, liver disease, or kidney disease.
• What to do if a dose is missed or if bleeding occurs.

FAQ

Source note: This article is based on the provided content and general FDA-linked reference resources for warfarin.